Vaxxas has received a manufacturing licence from Australia’s Therapeutic Goods Administration (TGA) for its high-density ...
A recent study highlights how DNA microarray technology enables high-throughput gene analysis, supporting variation detection, expression ...
Milestone enables GMP manufacturing to accelerate clinical trials and transform global vaccine delivery BRISBANE, Australia ...
Australian biotech innovator Vaxxas has secured a major milestone in its journey to revolutionise vaccine delivery. The ...
Gasparin et al. evaluated the analytical performance of the Hilab Lens point-of-care hematology device compared to conventional hematology. The Hilab Lens demonstrated high precision, strong ...